Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Buy | Transaction Date : 21/06/2018
Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 22/06/2018
Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 25/06/2018
Of Details DOD BIOTECH PUBLIC COMPANY LIMITED 2021 Company Year 31/12/2021 DOD BIOTECH PUBLIC COMPANY LIMITED 2021 Consolidated Year 31/12/2021 DOD BIOTECH PUBLIC COMPANY LIMITED 2021 Reviewed
concerning the issuance of bills of exchanges, the related receipt and payment transactions, the accounting records practice, and the questionable transactions of land sales and purchases. The company was also
related receipt and payment transactions, and the accounting records practice. The company was also required to examine the issue raised by the auditor whether the questionable transactions of land sales
practice, and the questionable transactions of land sales and purchases. The company was also ordered to rectify the annual financial statements for the year 2015 and the interim financial statements for the
required to examine the issue raised by the auditor whether the questionable transactions of land sales and purchases were in line with the normal course of business operation.Concurrently, the SEC
on, the interim financial statements for the third quarter of 2016. The auditor's report on the facts related to the questionable land sale and purchase transactions was also submitted to the KC Board